BRENTWOOD, Tenn.--(BUSINESS WIRE)--PathGroup, one of the largest private providers of anatomic pathology and clinical lab services in the U.S., today announced a recapitalization in partnership with Pritzker Group Private Capital.
Founded by a team of pathologists in 1965, PathGroup is a physician-led company currently working with more than 70 hospitals and thousands of group practices across the U.S. to deliver quality results with unmatched responsiveness. PathGroup’s more than 80 in-house physician experts include a comprehensive spectrum of pathology subspecialty areas supporting the company’s mission to improve patient outcomes through high-quality diagnostics and direct physician contact.
Pritzker Group Private Capital and co-investors including Vesey Street Capital Partners invested alongside PathGroup’s management team and pathologists, who continue to hold a significant ownership stake in PathGroup and will continue to lead the company’s growth as the preferred provider of comprehensive anatomic, clinical and molecular pathology services.
“Pritzker Group’s depth of resources, understanding of our business and long-term approach to building market-leading businesses makes them an ideal partner for PathGroup,” said Dr. Ben Davis, chairman, president and CEO of PathGroup. “We’re proud to join with Pritzker Group to support the next chapter in our company’s growth.”
“PathGroup has built an unparalleled reputation over 50 years by providing the highest level of services critical to patient success,” said Michael Dal Bello, healthcare investment partner for Pritzker Group Private Capital. “As a physician-led company, PathGroup truly understands the needs of its customers.”
MTS Health Partners served as financial advisor to PathGroup and its shareholders including Primus Capital, which previously led a growth investment in PathGroup in 2009.
About PathGroup
Founded in 1965, PathGroup is a premier provider of anatomic, clinical and molecular pathology services, as well as one of the largest providers of women’s health services in the United States. Privately held and physician-centric, PathGroup works seamlessly with customers to provide superior diagnostic services – a vital link in the cycle of patient relationships. PathGroup uses the latest in proprietary and industry standard technology to deliver fast, accurate results. The company provides clients with the highest quality of services available, consistently exceeding the expectations of physicians, employees, payers and most importantly, patients. One Lab; Total Service. For more information, visit pathgroup.com.
About Pritzker Group
Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which provides early-stage and growth venture funding to technology companies throughout the United States; and Asset Management, which partners with top-performing investment managers across global public markets.
Pritzker Group Private Capital acquires North America-based middle-market companies with leading positions in the manufactured products, services and healthcare sectors. The firm’s permanent, proprietary capital base allows for efficient decision making, broad flexibility with transaction structure and investment horizon, and alignment with management teams focused on creating long-term value. Pritzker Group brings significant resources, expertise and credibility in building businesses and is an ideal partner for entrepreneur- and family-owned companies. For more information, visit pritzkergroup.com.
